Forums and Workshop (September 12) - ET (Eastern Time, GMT-05:00)
Forums and Workshop (September 12) - ET (Eastern Time, GMT-05:00)
(1 Hour)
Essential Guide to Intellectual Property in Life Sciences Transactions and Protecting Medicines
Building a Desirable Intellectual Property Estate to Support Business Transactions and Protect Medicine
- Overview of Model Patent Estate
- Platform Technologies
- Drug Substance and Methods of Use
- Formulations and Methods of Manufacture
- Drug Label Instructions & Information
- Biomarkers and Other Technologies
- Offensive IP / Defensive IP
Freedom to Operate
- Timing and Scope of Patent Landscape Analysis
- How to Handle FTO Issues
Leveraging Your IP in Life Sciences Transactions
- Pre-Diligence Preparations
- Self Audit – do self audit
Standard list of IP diligence questions – make sure have answers for same and copies of the standard documents that will be requested
IP ownership (employee/contractor/vendor agreements; MTA/SRA), prior art analysis, FTO analysis, gov’t grant money, etc.
- Secure Strategic IP
- Accelerate examination to secure key patents
- Point Person - designate a point person who has knowledge of the IP Estate, the Product, and the Business Strategy
- Construct the IP Narrative
- Succinct and specific explanation for how Company IP protects current product candidates
- Data Room – well organized data room that has all the usual documents that will be requested
- Track what information is being shared / avoid accidental disclosures and/or violation of any export controls
(1 Hour)
For companies, founders, and entrepreneurs considering entrance into the public markets, this session will focus on the “3 Ps” of going public – preparation, path, and post-transaction; and the different ways to go public in challenging markets. Are you and your board prepared? What path is most appropriate for you: traditional or an alternative ‘going public avenue. How can you best prepare for success post-transaction?
Preparing to be Public, An Organization-Wide Process
Going public is a transformative event for an organization that is complex, requires significant attention for executive management, involves the entire organization and carries high execution risk. Whether you go public via a direct listing IPO, a SPAC, or other reverse merger, the level of effort and the cost of preparation should not be underestimated. Beginning preparation early enables an organization to better manage both.
Your key takeaways:
- Considerations to prepare your organization for going public
- How to assess overall readiness
- How to identify organizational gaps to address
The LSX Biotech Growth CEO Forum provides a unique, powerful and valuable space for the candid sharing of ideas and experience between 15-25 c-suite executives from privately-held biotechs at the seed round to pre-series A stage. The forum is designed to foster new ideas and create new relationships between attendees so that they can leave with tangible outcomes and that will drive their businesses and the sector forward.
The forum is an in-person c-suite forum where all participants are active discussants. It follows a strict Chatham House Rule policy and includes presentations, case studies and general discussion focused on brainstorming solutions to the current collective challenges of the group.
The forum is an invitation-only CEO forum where all participants are active discussants. It follows a Chatham House Rule policy and includes presentations, case studies and general discussion focused on brainstorming solutions to the current collective challenges of the group.
The forum features interactive peer review discussions from CEOs and Partners who put forward informative presentations or specific case studies, either success stories or current challenges, and the group asks questions and discusses the challenges around the topic, as well as solutions and ideas.